ROSA CERVANTES: Open Payments
NPI 1942789243 · FORT LEE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$496 in 5 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $496
Food & beverage: $496
| Company | Payments | Amount |
|---|---|---|
| Averitas Pharma Inc. | 2 | $150 |
| GENZYME CORPORATION | 1 | $127 |
| AstraZeneca Pharmaceuticals LP | 1 | $122 |
| Otsuka America Pharmaceutical, Inc. | 1 | $97 |
Products named: QUTENZA, DUPIXENT, TEZSPIRE.
Industry payments across VA — which companies pay providers there.
